Intracytoplasmic sperm injection (ICSI) has become routine in sport horse breeding, enabling foals from deceased stallions or competing mares. Critics question the durability and welfare of these 'test tube horses,' but scientific evidence shows no differences in performance or athleticism compared to naturally bred horses.
ICSI involves injecting a single sperm into a mare's egg in a lab, followed by embryo transfer to a recipient mare. Introduced in horses in the late 1990s, the technique faced initial caution due to lack of long-term data and confusion with more invasive methods like cloning. Professor Madeleine Campbell highlighted the 'yuck factor'—an unease with technologies altering nature—during a 2023 British Equine Veterinary Association debate. Anecdotes of issues were sometimes wrongly linked to ICSI rather than genetics or management. Now embedded in commercial sport horse breeding, excluding racing, ICSI expands access to valuable bloodlines without altering inheritance or performance fundamentals. Lorna Wilson of Elite Stallions noted early assumptions filled gaps in understanding: 'In the early years, there was a natural degree of caution… When that’s the case, assumptions can fill the gap.' She added that high-genetic-value combinations and invested management likely boost outcomes. Expert Carlos emphasized: 'Genetic quality and training environment remain fundamental determinants of performance.' No scientific evidence indicates ICSI horses are less durable or athletic. Welfare concerns arise from ovum pick-up, which uses ultrasound-guided needles under sedation, but it may reduce repeated interventions compared to some embryo transfer programs. Freezing embryos allows flexible transfers. Overall, ICSI serves as a tool for genetics preservation, with success depending on breeding choices, horsemanship, and opportunity.